Published in Am J Med Genet on August 23, 1996
Holoprosencephaly. Orphanet J Rare Dis (2007) 2.63
Holoprosencephaly: a paradigm for the complex genetics of brain development. J Inherit Metab Dis (1998) 1.56
Magnetic resonance microscopy defines ethanol-induced brain abnormalities in prenatal mice: effects of acute insult on gestational day 7. Alcohol Clin Exp Res (2009) 1.32
Clinical spectrum of SIX3-associated mutations in holoprosencephaly: correlation between genotype, phenotype and function. J Med Genet (2009) 1.31
Molecular evaluation of foetuses with holoprosencephaly shows high incidence of microdeletions in the HPE genes. Hum Genet (2005) 1.14
Targeted disruption of Tgif, the mouse ortholog of a human holoprosencephaly gene, does not result in holoprosencephaly in mice. Mol Cell Biol (2005) 1.10
Mutations in ZIC2 in human holoprosencephaly: description of a novel ZIC2 specific phenotype and comprehensive analysis of 157 individuals. J Med Genet (2009) 1.10
Loss of Tgif function causes holoprosencephaly by disrupting the SHH signaling pathway. PLoS Genet (2012) 1.10
Clinical characterization of individuals with deletions of genes in holoprosencephaly pathways by aCGH refines the phenotypic spectrum of HPE. Hum Genet (2010) 1.03
Holoprosencephaly and agnathia spectrum: Presentation of two new patients and review of the literature. Am J Med Genet C Semin Med Genet (2010) 1.01
Magnetic resonance-based imaging in animal models of fetal alcohol spectrum disorder. Neuropsychol Rev (2011) 0.99
MRI and 1H MRS findings in Smith-Lemli-Opitz syndrome. Neuroradiology (2003) 0.96
Cyclopia: an epidemiologic study in a large dataset from the International Clearinghouse of Birth Defects Surveillance and Research. Am J Med Genet C Semin Med Genet (2011) 0.88
Prenatal diagnosis of de novo proximal interstitial deletion of 14q associated with cebocephaly. J Med Genet (1997) 0.88
Holoprosencephaly: signaling interactions between the brain and the face, the environment and the genes, and the phenotypic variability in animal models and humans. Wiley Interdiscip Rev Dev Biol (2014) 0.88
Holoprosencephaly: a guide to diagnosis and clinical management. Indian Pediatr (2011) 0.83
Three unusual but cytogenetically similar cases with up to five different cell lines involving structural and numerical abnormalities of chromosome 18. J Histochem Cytochem (2007) 0.83
Links between abnormal brain structure and cognition in holoprosencephaly. Pediatr Neurol (2006) 0.80
Semilobar holoprosencephaly with 21q22 deletion: an autopsy report. BMJ Case Rep (2014) 0.75
Iniencephaly and holoprosencephaly: report of a rare association. Case Rep Obstet Gynecol (2014) 0.75
Molecular analysis of holoprosencephaly in South America. Genet Mol Biol (2014) 0.75
Otocephaly: Agnathia- Microstomia-Synotia Syndrome- A Rare Congenital Anomaly. J Clin Diagn Res (2015) 0.75
Semi Lobar Holoprosencephaly with Vertebral Segmentation Defects. Iran J Child Neurol (2017) 0.75
Holoprosencephaly: antenatal and postnatal diagnosis and outcome. Childs Nerv Syst (2016) 0.75
Virus-specific CD8+ cytotoxic T-lymphocyte activity associated with control of viremia in primary human immunodeficiency virus type 1 infection. J Virol (1994) 15.93
High levels of HIV-1 in plasma during all stages of infection determined by competitive PCR. Science (1993) 12.22
Antiviral pressure exerted by HIV-1-specific cytotoxic T lymphocytes (CTLs) during primary infection demonstrated by rapid selection of CTL escape virus. Nat Med (1997) 12.08
Origin of HIV-1 in the chimpanzee Pan troglodytes troglodytes. Nature (1999) 10.97
Identification and characterization of conserved and variable regions in the envelope gene of HTLV-III/LAV, the retrovirus of AIDS. Cell (1986) 10.70
Molecular characterization of human T-cell leukemia (lymphotropic) virus type III in the acquired immune deficiency syndrome. Science (1984) 10.40
Potent suppression of HIV-1 replication in humans by T-20, a peptide inhibitor of gp41-mediated virus entry. Nat Med (1998) 8.62
AIDS as a zoonosis: scientific and public health implications. Science (2000) 8.28
Genetic variation in HTLV-III/LAV over time in patients with AIDS or at risk for AIDS. Science (1986) 7.81
HTLV-III infection in brains of children and adults with AIDS encephalopathy. Science (1985) 7.70
High titers of cytopathic virus in plasma of patients with symptomatic primary HIV-1 infection. N Engl J Med (1991) 7.01
Sensitivity of human immunodeficiency virus type 1 to the fusion inhibitor T-20 is modulated by coreceptor specificity defined by the V3 loop of gp120. J Virol (2000) 6.71
Computer-assisted analysis of envelope protein sequences of seven human immunodeficiency virus isolates: prediction of antigenic epitopes in conserved and variable regions. J Virol (1987) 6.20
Retinoic acid embryopathy. N Engl J Med (1985) 5.85
Major expansion of CD8+ T cells with a predominant V beta usage during the primary immune response to HIV. Nature (1994) 5.68
Genomic diversity of human T-lymphotropic virus type III (HTLV-III). Science (1985) 5.33
Macrophage tropism determinants of human immunodeficiency virus type 1 in vivo. J Virol (1992) 5.19
Genomic diversity of the acquired immune deficiency syndrome virus HTLV-III: different viruses exhibit greatest divergence in their envelope genes. Proc Natl Acad Sci U S A (1985) 5.10
Extensive variation of human immunodeficiency virus type-1 in vivo. Nature (1988) 5.02
HIV viral load markers in clinical practice. Nat Med (1996) 4.78
Quantitating the multiplicity of infection with human immunodeficiency virus type 1 subtype C reveals a non-poisson distribution of transmitted variants. J Virol (2009) 4.40
Molecular cloning and characterization of the HTLV-III virus associated with AIDS. Nature (1984) 4.35
Neutralizing antibody responses in acute human immunodeficiency virus type 1 subtype C infection. J Virol (2007) 4.13
Human infection by genetically diverse SIVSM-related HIV-2 in west Africa. Nature (1992) 4.11
Miscarriage and use of multi-vitamins or folic acid. Am J Med Genet (2000) 3.95
The heterosexual human immunodeficiency virus type 1 epidemic in Thailand is caused by an intersubtype (A/E) recombinant of African origin. J Virol (1996) 3.82
Biologically diverse molecular variants within a single HIV-1 isolate. Nature (1988) 3.80
Genetic diversity of human immunodeficiency virus type 2: evidence for distinct sequence subtypes with differences in virus biology. J Virol (1994) 3.70
A comprehensive panel of near-full-length clones and reference sequences for non-subtype B isolates of human immunodeficiency virus type 1. J Virol (1998) 3.65
Virus dynamics and drug therapy. Proc Natl Acad Sci U S A (1997) 3.63
Risks of orofacial clefts in children born to women using multivitamins containing folic acid periconceptionally. Lancet (1995) 3.48
A novel and ubiquitous system for membrane targeting and secretion of cofactor-containing proteins. Cell (1998) 3.33
Mosaic genome structure of simian immunodeficiency virus from west African green monkeys. EMBO J (1994) 3.19
Complete nucleotide sequence, genome organization, and biological properties of human immunodeficiency virus type 1 in vivo: evidence for limited defectiveness and complementation. J Virol (1992) 2.86
Species-specific diversity among simian immunodeficiency viruses from African green monkeys. J Virol (1991) 2.70
Characteristics of hazardous material spills from reporting systems in California. Am J Public Health (1986) 2.36
Anti-viral drug treatment: dynamics of resistance in free virus and infected cell populations. J Theor Biol (1997) 2.30
Reporting and selection bias in case-control studies of congenital malformations. Epidemiology (1992) 2.27
Maternal residential proximity to hazardous waste sites and risk for selected congenital malformations. Epidemiology (1997) 2.26
The Vif protein of human and simian immunodeficiency viruses is packaged into virions and associates with viral core structures. J Virol (1995) 2.25
Location and chemical synthesis of a binding site for HIV-1 on the CD4 protein. Science (1988) 2.24
The qualitative nature of the primary immune response to HIV infection is a prognosticator of disease progression independent of the initial level of plasma viremia. Proc Natl Acad Sci U S A (1997) 2.24
Near full-length clones and reference sequences for subtype C isolates of HIV type 1 from three different continents. AIDS Res Hum Retroviruses (2001) 2.23
Birth defects monitoring in California: a resource for epidemiological research. Paediatr Perinat Epidemiol (1991) 2.17
Birth prevalence study of the Apert syndrome. Am J Med Genet (1992) 2.10
Constant mean viral copy number per infected cell in tissues regardless of high, low, or undetectable plasma HIV RNA. J Exp Med (1999) 1.96
High-level viremia in adults and children infected with human immunodeficiency virus: relation to disease stage and CD4+ lymphocyte levels. J Infect Dis (1991) 1.94
Chorionic villus sampling and transverse digital deficiencies: evidence for anatomic and gestational-age specificity of the digital deficiencies in two studies. Am J Med Genet (1996) 1.92
Molecular characterization of an attenuated human immunodeficiency virus type 2 isolate. J Virol (1990) 1.86
West African HIV-2-related human retrovirus with attenuated cytopathicity. Science (1988) 1.86
Socioeconomic status, neighborhood social conditions, and neural tube defects. Am J Public Health (1998) 1.85
A molecular clone of HIV-1 tropic and cytopathic for human and chimpanzee lymphocytes. Virology (1993) 1.83
Maternal vitamin use, genetic variation of infant methylenetetrahydrofolate reductase, and risk for spina bifida. Am J Epidemiol (1998) 1.80
Human papillomavirus DNA replication compartments in a transient DNA replication system. J Virol (1999) 1.76
Intracellular transport and virion incorporation of vpx requires interaction with other virus type-specific components. Virology (1993) 1.75
Verification of the fetal valproate syndrome phenotype. Am J Med Genet (1988) 1.71
Orofacial clefts, parental cigarette smoking, and transforming growth factor-alpha gene variants. Am J Hum Genet (1996) 1.71
Infection of a yellow baboon with simian immunodeficiency virus from African green monkeys: evidence for cross-species transmission in the wild. J Virol (1994) 1.70
Homology of genome of AIDS-associated virus with genomes of human T-cell leukemia viruses. Science (1984) 1.69
Teratogen update: valproic acid. Teratology (1987) 1.68
Maternal periconceptional use of multivitamins and reduced risk for conotruncal heart defects and limb deficiencies among offspring. Am J Med Genet (1995) 1.67
Identification of a novel retroviral gene unique to human immunodeficiency virus type 2 and simian immunodeficiency virus SIVMAC. J Virol (1988) 1.66
Human immunodeficiency virus type 2 vpx protein augments viral infectivity. Virology (1991) 1.65
Lamina propria lymphocytes, not macrophages, express CCR5 and CXCR4 and are the likely target cell for human immunodeficiency virus type 1 in the intestinal mucosa. J Infect Dis (2000) 1.62
Genomes of evolutionarily divergent members of the human T-cell leukemia virus family (HTLV-I and HTLV-II) are highly conserved, especially in pX. Proc Natl Acad Sci U S A (1984) 1.55
Kinetics of human immunodeficiency virus type 1 (HIV-1) DNA and RNA synthesis during primary HIV-1 infection. Proc Natl Acad Sci U S A (1993) 1.54
Relation of HTLV-4 to simian and human immunodeficiency-associated viruses. Nature (1987) 1.53
Determination of plasma viral load in HIV-1 infection by quantitative competitive polymerase chain reaction. AIDS (1993) 1.48
Does periconceptional multivitamin use reduce the risk of neural tube defects associated with other birth defects? data from two population-based case-control studies. Am J Med Genet (1996) 1.48
Complementation of integrase function in HIV-1 virions. EMBO J (1997) 1.46
Kinetics of cytokine expression during primary human immunodeficiency virus type 1 infection. Proc Natl Acad Sci U S A (1996) 1.44
Maternal vitamin A supplementation in relation to selected birth defects. Teratology (1990) 1.42
Racial and ethnic variations in the prevalence of orofacial clefts in California, 1983-1992. Am J Med Genet (1998) 1.42
Identification of novel candidate genes associated with cleft lip and palate using array comparative genomic hybridisation. J Med Genet (2007) 1.40
A novel, model-based insulin and nutrition delivery controller for glycemic regulation in critically ill patients. Diabetes Technol Ther (2006) 1.40
Feasibility of collecting maternal blood and hair samples in a case-control study of congenital anomalies. Epidemiology (1995) 1.38
Common themes of antibody maturation to simian immunodeficiency virus, simian-human immunodeficiency virus, and human immunodeficiency virus type 1 infections. J Virol (1998) 1.38
Infant C677T mutation in MTHFR, maternal periconceptional vitamin use, and cleft lip. Am J Med Genet (1998) 1.33
Maternal exposure to nitrate from drinking water and diet and risk for neural tube defects. Am J Epidemiol (2001) 1.31
A full-length and replication-competent proviral clone of SIVAGM from tantalus monkeys. Virology (1997) 1.30
Distinguishing between HTLV-I and HTLV-II by western blot. Lancet (1990) 1.27
An isolate of human immunodeficiency virus type 1 originally classified as subtype I represents a complex mosaic comprising three different group M subtypes (A, G, and I). J Virol (1998) 1.26
The population-based prevalence of achondroplasia and thanatophoric dysplasia in selected regions of the US. Am J Med Genet A (2008) 1.25
Risk factors for cytogenetically normal holoprosencephaly in California: a population-based case-control study. Am J Med Genet (2000) 1.24
Nucleotide sequence analysis of a variant human T-cell leukemia virus (HTLV-Ib) provirus with a deletion in pX-I. J Virol (1985) 1.23
Endemic human T cell lymphotropic virus type II infection among isolated Brazilian Amerindians. J Infect Dis (1992) 1.22
Maternal illness, including fever and medication use as risk factors for neural tube defects. Teratology (1998) 1.21
Virologic and immunologic characterization of symptomatic and asymptomatic primary HIV-1 infection. J Acquir Immune Defic Syndr Hum Retrovirol (1995) 1.20
Human monocyte, lymphocyte, and granulocyte antibody-dependent cell-mediated cytotoxicity toward tumor cells. I. General characteristics of cytolysis. J Immunol (1979) 1.20
Functional analysis of the simian immunodeficiency virus Vpx protein: identification of packaging determinants and a novel nuclear targeting domain. J Virol (2001) 1.20
Maternal corticosteroid use and risk of selected congenital anomalies. Am J Med Genet (1999) 1.18
Cytotoxic T-lymphocyte escape viral variants: how important are they in viral evasion of immune clearance in vivo? Immunol Rev (1998) 1.17
Transfusion transmission of retroviruses: human T-lymphotropic virus types I and II compared with human immunodeficiency virus type 1. Transfusion (1994) 1.16
Characterization of CFTR expression and chloride channel activity in human endothelia. Am J Physiol (1998) 1.16
Maternal life event stress and congenital anomalies. Epidemiology (2000) 1.16